Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Canaccord Genuity analyst Edward Nash initiated coverage on Sagimet Biosciences Inc. (NASDAQ:SGMT) with a Buy rating and announced a price target of $28. Sagimet Biosciences shares closed at $9.59 on Wednesday. See how other analysts view this stock.
- Citigroup analyst Yigal Nochomovitz initiated coverage on Sarepta Therapeutics, Inc. (NASDAQ:SRPT) with a …
Full story available on Benzinga.com
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Canaccord Genuity analyst Edward Nash initiated coverage on Sagimet Biosciences Inc. (NASDAQ:SGMT) with a Buy rating and announced a price target of $28. Sagimet Biosciences shares closed at $9.59 on Wednesday. See how other analysts view this stock.
- Citigroup analyst Yigal Nochomovitz initiated coverage on Sarepta Therapeutics, Inc. (NASDAQ:SRPT) with a …
Full story available on Benzinga.com
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Canaccord Genuity analyst Edward Nash initiated coverage on Sagimet Biosciences Inc. (NASDAQ:SGMT) with a Buy rating and announced a price target of $28. Sagimet Biosciences shares closed at $9.59 on Wednesday. See how other analysts view this stock.
Citigroup analyst Yigal Nochomovitz initiated coverage on Sarepta Therapeutics, Inc. (NASDAQ:SRPT) with a …Full story available on Benzinga.com Read MoreBRZE, EPRX, ESLT, News, SGMT, SRPT, Top Initiations, Price Target, Initiation, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas, ESLT, IL0010811243, SRPT, BRZE, SGMT, EPRX, News, Price Target, Initiation, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas, Benzinga Markets
